Sarah M. McLeod

2.2k total citations
49 papers, 1.4k citations indexed

About

Sarah M. McLeod is a scholar working on Molecular Medicine, Pharmacology and Epidemiology. According to data from OpenAlex, Sarah M. McLeod has authored 49 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Molecular Medicine, 22 papers in Pharmacology and 11 papers in Epidemiology. Recurrent topics in Sarah M. McLeod's work include Antibiotic Resistance in Bacteria (32 papers), Antibiotics Pharmacokinetics and Efficacy (20 papers) and Vibrio bacteria research studies (10 papers). Sarah M. McLeod is often cited by papers focused on Antibiotic Resistance in Bacteria (32 papers), Antibiotics Pharmacokinetics and Efficacy (20 papers) and Vibrio bacteria research studies (10 papers). Sarah M. McLeod collaborates with scholars based in United States, United Kingdom and Canada. Sarah M. McLeod's co-authors include Alita A. Miller, Reid C. Johnson, Matthew K. Waldor, Samir H. Moussa, Meredith Hackel, Adam B. Shapiro, Richard L. Gourse, Sarah E. Aiyar, James A. Karlowsky and Dunja Skoko and has published in prestigious journals such as Journal of Biological Chemistry, Angewandte Chemie International Edition and PLoS ONE.

In The Last Decade

Sarah M. McLeod

49 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sarah M. McLeod United States	23	579	577	401	307	250	49	1.4k
Denis M. Daigle Canada	19	695 1.2×	614 1.1×	281 0.7×	273 0.9×	93 0.4×	28	1.3k
Ryan T. Cirz United States	13	757 1.3×	577 1.0×	536 1.3×	221 0.7×	95 0.4×	18	1.3k
Javier Sánchez‐Céspedes Spain	21	506 0.9×	651 1.1×	215 0.5×	239 0.8×	281 1.1×	51	1.4k
Nobuhisa Masuda Japan	21	1.2k 2.1×	1.4k 2.4×	679 1.7×	544 1.8×	381 1.5×	39	2.4k
Rafael Peña‐Miller Mexico	16	435 0.8×	468 0.8×	535 1.3×	94 0.3×	166 0.7×	28	1.1k
Monique Malléa France	16	391 0.7×	791 1.4×	266 0.7×	297 1.0×	269 1.1×	23	1.2k
Samir H. Moussa United States	17	325 0.6×	434 0.8×	116 0.3×	251 0.8×	100 0.4×	29	852
Satoshi Ohya Japan	22	914 1.6×	1.5k 2.6×	389 1.0×	706 2.3×	268 1.1×	68	2.2k
Brian J. Morrow United States	19	443 0.8×	362 0.6×	118 0.3×	226 0.7×	109 0.4×	33	1.2k
Mami Nakamura Japan	11	754 1.3×	912 1.6×	169 0.4×	495 1.6×	152 0.6×	58	1.6k

Countries citing papers authored by Sarah M. McLeod

Since Specialization

Citations

This map shows the geographic impact of Sarah M. McLeod's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah M. McLeod with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah M. McLeod more than expected).

Fields of papers citing papers by Sarah M. McLeod

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah M. McLeod. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah M. McLeod. The network helps show where Sarah M. McLeod may publish in the future.

Co-authorship network of co-authors of Sarah M. McLeod

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah M. McLeod. A scholar is included among the top collaborators of Sarah M. McLeod based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah M. McLeod. Sarah M. McLeod is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

McLeod, Sarah M., John P. O’Donnell, Navaneeth Narayanan, John Mills, & Keith S. Kaye. (2024). Sulbactam–durlobactam: a β-lactam/β-lactamase inhibitor combination targeting Acinetobacter baumannii. Future Microbiology. 19(7). 563–576. 15 indexed citations

McLeod, Sarah M., Alita A. Miller, Khurram Rana, et al.. (2024). Clinical Outcomes for Patients With Monomicrobial vs Polymicrobial Acinetobacter baumannii-calcoaceticus Complex Infections Treated With Sulbactam-Durlobactam or Colistin: A Subset Analysis From a Phase 3 Clinical Trial. Open Forum Infectious Diseases. 11(4). ofae140–ofae140. 7 indexed citations

McLeod, Sarah M., Nicole Carter, Patricia A. Bradford, & Alita A. Miller. (2024). In vitro antibacterial activity of sulbactam-durlobactam in combination with other antimicrobial agents against Acinetobacter baumannii-calcoaceticus complex. Diagnostic Microbiology and Infectious Disease. 109(3). 116344–116344. 5 indexed citations

Miller, Alita A., Samir H. Moussa, & Sarah M. McLeod. (2024). Characterization of Acinetobacter baumannii-calcoaceticus complex isolates and microbiological outcome for patients treated with sulbactam-durlobactam in a phase 3 trial (ATTACK). Antimicrobial Agents and Chemotherapy. 68(5). e0169823–e0169823. 9 indexed citations

Papp‐Wallace, Krisztina M., Sarah M. McLeod, & Alita A. Miller. (2023). Durlobactam, a Broad-Spectrum Serine β-lactamase Inhibitor, Restores Sulbactam Activity AgainstAcinetobacterSpecies. Clinical Infectious Diseases. 76(Supplement_2). S194–S201. 23 indexed citations

Moussa, Samir H., Adam B. Shapiro, Sarah M. McLeod, et al.. (2023). Molecular drivers of resistance to sulbactam-durlobactam in contemporary clinical isolates ofAcinetobacter baumannii. Antimicrobial Agents and Chemotherapy. 67(11). e0066523–e0066523. 23 indexed citations

McLeod, Sarah M., Nicole Carter, Michael D. Huband, et al.. (2023). Sulbactam-durlobactam susceptibility test method development and quality control ranges for MIC and disk diffusion tests. Journal of Clinical Microbiology. 62(1). e0122823–e0122823. 6 indexed citations

McLeod, Sarah M., Nicole Carter, Samir H. Moussa, & Alita A. Miller. (2023). 2138. In Vitro Susceptibility of Recent Clinical Isolates of P. aeruginosa and Enterobacterales to Imipenem or Meropenem Alone or in Combination with Sulbactam-Durlobactam. Open Forum Infectious Diseases. 10(Supplement_2). 1 indexed citations

Branting, L. Karl, Sarah M. McLeod, Sarah L. Howell, et al.. (2022). A computational model of facilitation in online dispute resolution. Artificial Intelligence and Law. 31(3). 465–490. 3 indexed citations

10.

McLeod, Sarah M., Adam B. Shapiro, Samir H. Moussa, et al.. (2017). Frequency and Mechanism of Spontaneous Resistance to Sulbactam Combined with the Novel β-Lactamase Inhibitor ETX2514 in Clinical Isolates of Acinetobacter baumannii. Antimicrobial Agents and Chemotherapy. 62(2). 54 indexed citations

11.

Duvall, Jeremy R., Lynn VerPlank, Barbara Ludeke, et al.. (2016). Novel diversity-oriented synthesis-derived respiratory syncytial virus inhibitors identified via a high throughput replicon-based screen. Antiviral Research. 131. 19–25. 11 indexed citations

12.

Ma, Junhe, Qing Cao, Sarah M. McLeod, et al.. (2015). Target‐Based Whole‐Cell Screening by ¹H NMR Spectroscopy. Angewandte Chemie. 127(16). 4846–4849. 3 indexed citations

13.

Ma, Junhe, Qing Cao, Sarah M. McLeod, et al.. (2015). Target‐Based Whole‐Cell Screening by ¹H NMR Spectroscopy. Angewandte Chemie International Edition. 54(16). 4764–4767. 16 indexed citations

14.

Gao, Ning, Sarah M. McLeod, Laurel Hajec, et al.. (2014). Overexpression of Pseudomonas aeruginosa LpxC with its inhibitors in an acrB-deficient Escherichia coli strain. Protein Expression and Purification. 104. 57–64. 6 indexed citations

15.

Ferguson, Andrew D., Paul Fleming, Ning Gao, et al.. (2014). The Role of a Novel Auxiliary Pocket in Bacterial Phenylalanyl-tRNA Synthetase Druggability. Journal of Biological Chemistry. 289(31). 21651–21662. 25 indexed citations

16.

Liu, Mingyu, Sarah M. McLeod, John Wiseman, et al.. (2014). Secreted Gaussia princeps Luciferase as a Reporter of Escherichia coli Replication in a Mouse Tissue Cage Model of Infection. PLoS ONE. 9(3). e90382–e90382. 9 indexed citations

17.

Cheyne, Helen, Len Dalgleish, Janet Tucker, et al.. (2012). Risk assessment and decision making about in-labour transfer from rural maternity care: a social judgment and signal detection analysis. BMC Medical Informatics and Decision Making. 12(1). 122–122. 29 indexed citations

18.

McLeod, Sarah M., et al.. (2009). An HPV 16, 18, and 45 genotyping test based on Hybrid Capture® technology. Journal of Clinical Virology. 45. S93–S97. 12 indexed citations

19.

McLeod, Sarah M., Sarah E. Aiyar, Richard L. Gourse, & Reid C. Johnson. (2002). The C-terminal domains of the RNA polymerase α subunits: contact site with fis and localization during co-activation with CRP at the Escherichia coli proP P2 promoter. Journal of Molecular Biology. 316(3). 517–529. 61 indexed citations

20.

McLeod, Sarah M., Jimin Xu, & Reid C. Johnson. (2000). Coactivation of the RpoS-Dependent proP P2 Promoter by Fis and Cyclic AMP Receptor Protein. Journal of Bacteriology. 182(15). 4180–4187. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact